Immuno - Resources

Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.

Events

In-Person & Online Events

Pivotal moments where high-level industry experts and thought leaders come together for focused knowledge sharing and unparalleled networking opportunities.

All Immuno Programmes

Immuno US 2024

28 - 29 Oct 2024

San Diego, CA

Microbiome Drug Development Online Symposium

24 Sep 2024

Online, BST (UTC+1)

Online Activities

Our Monthly Science Exchanges and Webinars keep you connected to the conversation.

All Online Activities
Community

Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

More Info

Sponsors

Our range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

More Info

Media Partners

We work with leading journal publications on reciprocal marketing arrangements.

More Info
Services

In-Person Services

At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.

More Info

Digital Marketing Services

Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.

More Info
Resources

Browse All Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies.

All Immuno Resources

Latest Resources

Regeneron’s Bispecific Gets EU Approval After FDA Rejection

29/08/24 - The approval means that the bispecific antibody odronextamab can be used to treat adult patients with relapsed or refractory follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) in the EU.

15/08/24 - MSD to Acquire Bispecific Antibody From Curon in Bid to Diversify Portfolio

30/07/24 - CAR T Beyond Cancer: Applying the Cell Therapy for Lupus and Other Autoimmune Diseases

Featured Resource

Unlocking the Future of Immune Cancer Therapy

A concise report featuring insights from the prominent though leaders of Immuno 2024.
PLUS Pass
Contact
Our Brands

Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.

Oxford Global

Biologics & Tides

Biomarkers

Cell & Gene

Discovery

Formulation & Delivery

Immuno

Omics

Unlocking the Future of Immune Cancer Therapy

A concise report featuring insights from the prominent though leaders of Immuno 2024.

Read Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Read Now